Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 12Active not recruiting 3Unknown 1Terminated 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 104Lymphoma 78Lung Neoplasms 68Colorectal Neoplasms 61Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 58Leukemia 56Colonic Neoplasms 56Lymphoma, Follicular 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Central Nervous System Neoplasms 39Lymphoma, Large B-Cell, Diffuse 38Prostatic Neoplasms 35Ovarian Neoplasms 33Melanoma 33Lymphoma, Non-Hodgkin 33Head and Neck Neoplasms 32Burkitt Lymphoma 31Leukemia, Lymphocytic, Chronic, B-Cell 30Carcinoma, Ovarian Epithelial 30Lymphoma, Large-Cell, Immunoblastic 28Kidney Neoplasms 28Multiple Myeloma 26Lymphoma, Mantle-Cell 26Lymphoma, B-Cell, Marginal Zone 25Carcinoma, Renal Cell 25Sarcoma 24Neoplasms, Plasma Cell 24Leukemia, Myeloid, Acute 24Hodgkin Disease 23

Interventions

Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × NIH × Brenner Tumor × Clear all
NCT00017303 2013-11-06

Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gynecologic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡